Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilance
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Thursday, April 25, 2024
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilance
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilance
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
admin
-
March 8, 2024
Latest Pharma-News
FDA Clears First Over-the-Counter Continuous Glucose Monitor
admin
-
March 8, 2024
Latest Pharma-News
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
admin
-
March 1, 2024
Latest Pharma-News
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
admin
-
February 3, 2024
Latest Pharma-News
BlueRock Therapeutics exercises exclusive option to license iPSC cell therapy candidate OpCT-001 for Primary Photoreceptor Diseases
admin
-
February 1, 2024
Latest Pharma-News
Novartis announces plan to initiate clinical trial of canakinumab for patients with COVID-19 pneumonia
admin
-
April 29, 2020
0
Latest Pharma-News
Neurocrine Biosciences Announces FDA Approval of Once-Daily ONGENTYS® (opicapone) as an Add-On Treatment for Patients with Parkinson’s Disease Experiencing “Off” Episodes
admin
-
April 28, 2020
0
Latest Pharma-News
Sanofi and Regeneron provide an update on U.S. Phase 2/3 adaptive-designed trial of Kevzara® (sarilumab) in hospitalized COVID-19 patients
admin
-
April 28, 2020
0
Latest Pharma-News
Sanofi: Phase 3 trial of Libtayo® (cemiplimab) as monotherapy for first-line advanced non-small cell lung cancer stopped early due to highly significant improvement in...
admin
-
April 28, 2020
0
Latest Pharma-News
Coronavirus (COVID-19) Update: FDA Continues to Ensure Availability of Alcohol-Based Hand Sanitizer During the COVID-19 Pandemic, Addresses Safety Concerns
admin
-
April 27, 2020
0
Latest Pharma-News
FDA Warns Manufacturers and Retailers to Remove Certain E-cigarette Products Targeted to Youth from the Market
admin
-
April 27, 2020
0
Latest Pharma-News
Novacyt contract with the UK Department of Health and Social Care for the supply of COVID-19 PCR tests
admin
-
April 27, 2020
0
Latest Pharma-News
FDA Warns of Heart Risks With Trump-Promoted Malaria Drug
admin
-
April 25, 2020
0
Latest Pharma-News
FDA approves MenQuadfiTM, the latest innovation in meningococcal (MenACWY) vaccination
admin
-
April 25, 2020
0
Latest Pharma-News
Global leaders unite to ensure everyone everywhere can access new vaccines, tests and treatments for COVID-19
admin
-
April 25, 2020
0
Latest Pharma-News
Scancell to initiate development of novel DNA vaccine against COVID-19
admin
-
April 25, 2020
0
Latest Pharma-News
Lynparza demonstrated overall survival benefit in Phase III PROfound trial for BRCA1/2 or ATM-mutated metastatic castration-resistant prostate cancer
admin
-
April 24, 2020
0
1
...
117
118
119
...
144
Page 118 of 144
- Advertisment -
Most Read
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
March 8, 2024
FDA Clears First Over-the-Counter Continuous Glucose Monitor
March 8, 2024
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
March 1, 2024
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
February 3, 2024